Wednesday August 5, 2026 7:45 PM ET

UPDATE - LifeMD Reports Second Quarter 2026 Results

Wednesday August 5, 2026 4:11 PM ET

LifeMD Reports Second Quarter 2026 Results

Friday July 24, 2026 4:05 PM ET

LifeMD to Report Second Quarter 2026 Financial Results on August 5

Tuesday June 23, 2026 8:00 AM ET

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

Monday June 1, 2026 8:05 AM ET

LifeMD Appoints Umesh Sripad as Chief Technology Officer

Wednesday May 6, 2026 4:05 PM ET

LifeMD Reports First Quarter 2026 Results

Monday April 27, 2026 8:00 AM ET

LifeMD to Report First Quarter 2026 Financial Results on May 6

Friday April 10, 2026 8:15 AM ET

LifeMD® Now Offering Eli Lilly and Company’s Foundayo™ (orforglipron), a New GLP-1 Pill for Weight Management

Tuesday March 31, 2026 8:45 AM ET

LifeMD Offers Novo Nordisk's Industry-First Wegovy® Telehealth Subscription Program

Tuesday March 24, 2026 4:05 PM ET

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

Monday March 16, 2026 8:00 AM ET

LifeMD Appoints Veteran Healthcare Finance Executive as Chief Financial Officer and Expands Leadership Team

Monday March 9, 2026 4:05 PM ET

LifeMD Reports Fourth Quarter and Full Year 2025 Results

Monday February 23, 2026 8:00 AM ET

LifeMD to Report Fourth Quarter 2025 Financial Results on March 9